aap is a global medical device company headquartered in Berlin, Germany, that develops, manufactures and markets innovative biomaterials and implants that are used in orthopedic procedures. The company’s products are primarily used in the orthopedic specialty areas of trauma and spine repair. aap sells its products through its direct sales force, distribution partners and license agreements with OEM partners.
aap’s stock is listed in the Prime Standard segment of the Frankfurt Stock Exchange (XETRA: AAQ.DE).
click , to go directly to the company website, www.aap.de